Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
27 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Tokai Pharmaceuticals, Inc. (Tokai Pharma) is a biopharmaceutical company that develops and commercializes therapies for the treatment of prostate cancer and other hormonally-driven diseases. The companys lead drug candidate, galeterone, an oral small molecule drug candidate which is intended for the treatment of patients with metastatic castration-resistant prostate cancer. Its pipeline also includes androgen receptor degradation agents (ARDA) drug discovery program, to identify and develop compounds for androgen receptor degradation activity. The company has collaboration with pharmaceutical companies to enhance its product candidates.

Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed

  
Source:
Document ID
GDPH135289D
Country
Industry
Ticker
TKAI=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Tokai Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016101
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016111
Tokai Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1212
  Venture Financing121
    Tokai Pharma Raises US$35.5 Million In Series E Financing122
    Tokai Pharma Raises US$23 Million In Series D3 Financing142
  Partnerships161
    Tokai Pharma Expands Agreement with Qiagen161
    Tokai Pharma Enters into Agreement with Qiagen171
  Licensing Agreements181
    Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University181
    Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore191
    Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore201
  Equity Offering211
    Tokai Pharma Raises USD0.71 Million in Public Offering of Shares211
    Tokai Pharma Raises USD97.2 Million in IPO222
Tokai Pharmaceuticals, Inc. - Key Competitors241
Key Employees251
Locations And Subsidiaries261
  Head Office261
Appendix271
  Methodology271
  About GlobalData271
  Contact Us271
  Disclaimer271

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tokai-Pharmaceuticals-Inc-TKAI-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-11670>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Tokai Pharmaceuticals, Inc. (TKAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Tokai-Pharmaceuticals-Inc-TKAI-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-11670>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research